Published in Neurology on February 13, 2013
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain (2015) 1.09
Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke (2015) 1.07
MRI and MRS predictors of mild cognitive impairment in a population-based sample. Neurology (2013) 1.00
Antemortem MRI findings associated with microinfarcts at autopsy. Neurology (2014) 0.93
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83
Effects of hormone therapy on brain structure: A randomized controlled trial. Neurology (2016) 0.82
Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles. Platelets (2015) 0.80
Menopausal hot flashes and white matter hyperintensities. Menopause (2016) 0.80
Midlife and Late-Life Vascular Risk Factors and White Matter Microstructural Integrity: The Atherosclerosis Risk in Communities Neurocognitive Study. J Am Heart Assoc (2017) 0.77
Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women. Atherosclerosis (2015) 0.77
Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease. J Womens Health (Larchmt) (2014) 0.77
Atrial fibrillation, cognitive impairment, and neuroimaging. Alzheimers Dement (2015) 0.76
Aortic hemodynamics and white matter hyperintensities in normotensive postmenopausal women. J Neurol (2017) 0.75
Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC). PLoS One (2016) 0.75
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimers Dement (2016) 0.75
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol (2017) 0.75
White-matter integrity on DTI and the pathologic staging of Alzheimer's disease. Neurobiol Aging (2017) 0.75
Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study. J Alzheimers Dis (2016) 0.75
Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy. J Hypertens (2017) 0.75
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Unified segmentation. Neuroimage (2005) 30.20
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke (2004) 4.56
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Cell biology of atherosclerosis. Annu Rev Physiol (1995) 3.60
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke (2008) 2.48
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke (2009) 2.30
Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol (2001) 2.22
Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke (2008) 2.21
Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology (2008) 2.00
Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke (2009) 1.66
Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study. Stroke (2002) 1.64
Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods (2011) 1.58
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Cognitive impairment risk: white matter hyperintensity progression matters. Neurology (2009) 1.46
Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol (2008) 1.44
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology (2009) 1.30
Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta (2011) 1.29
Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke (2008) 1.19
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab (2006) 1.14
Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11
Self-reported cognitive functioning in formerly eclamptic women. Am J Obstet Gynecol (2007) 1.10
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol (2004) 1.03
Potential roles of cell-derived microparticles in ischemic brain disease. Neurol Res (2009) 0.99
Increased brachial-ankle pulse wave velocity is independently associated with white matter hyperintensities. Neuroepidemiology (2011) 0.97
The spatial distribution of age-related white matter changes as a function of vascular risk factors--results from the LADIS study. Neuroimage (2012) 0.96
White matter lesions on brain magnetic resonance imaging scan and 5-year cognitive decline: the Honolulu-Asia aging study. J Am Geriatr Soc (2011) 0.95
Estrogen, inflammation, and platelet phenotype. Gend Med (2008) 0.92
Brain lesions several years after eclampsia. Am J Obstet Gynecol (2009) 0.92
Platelet characteristics associated with coronary artery disease. J Thromb Haemost (2003) 0.91
Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. J Clin Hypertens (Greenwich) (2010) 0.90
Older age and greater carotid intima-media thickness predict ischemic events associated with carotid-artery stenting. Cerebrovasc Dis (2010) 0.86
Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol (2012) 0.86
Ageing, oestrogen, platelets and thrombotic risk. Clin Exp Pharmacol Physiol (2007) 0.85
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet (2005) 6.86
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Mild cognitive impairment: ten years later. Arch Neurol (2009) 5.02
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol (2012) 4.36
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain (2006) 4.07
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA (2010) 3.58
Testing the right target and right drug at the right stage. Sci Transl Med (2011) 3.55
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
E2-2 protein and Fuchs's corneal dystrophy. N Engl J Med (2010) 3.31
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage (2010) 3.27
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain (2012) 3.08
Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage (2005) 3.06
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 2.86
Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol (2011) 2.83
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68
Magnetic resonance elastography of the brain. Neuroimage (2007) 2.59
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain (2007) 2.58
Brain β-amyloid load approaches a plateau. Neurology (2013) 2.50
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48
Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion (2006) 2.45
Neuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am (2003) 2.43
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain (2012) 2.43
Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med (2009) 2.43
Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol (2011) 2.40
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Association of ambulatory blood pressure with ischemic brain injury. Hypertension (2007) 2.39
Predicting clinical scores from magnetic resonance scans in Alzheimer's disease. Neuroimage (2010) 2.33
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain (2012) 2.29
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol (2010) 2.16
Methodological considerations for measuring rates of brain atrophy. J Magn Reson Imaging (2003) 2.16
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol (2012) 2.09
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Brain injury biomarkers are not dependent on β-amyloid in normal elderly. Ann Neurol (2013) 2.03
Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology (2006) 2.01
Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology (2012) 2.01